Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001866829 | SCV002117779 | pathogenic | not provided | 2024-01-26 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Tyr29*) in the TRMU gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TRMU are known to be pathogenic (PMID: 19732863, 23625533). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with TRMU-related conditions. ClinVar contains an entry for this variant (Variation ID: 1355265). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV002506887 | SCV002809896 | likely pathogenic | Aminoglycoside-induced deafness; Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins | 2022-01-07 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003475118 | SCV004204350 | likely pathogenic | Aminoglycoside-induced deafness | 2023-10-11 | criteria provided, single submitter | clinical testing |